These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
200 related articles for article (PubMed ID: 3430963)
1. Role of 1,25-dihydroxyvitamin D on the skeletal resistance to parathyroid hormone. Galceran T; Martin KJ; Morrissey JJ; Slatopolsky E Kidney Int; 1987 Dec; 32(6):801-7. PubMed ID: 3430963 [TBL] [Abstract][Full Text] [Related]
2. Skeletal resistance to the calcemic action of parathyroid hormone in uremia: role of 1,25 (OH)2 D3. Massry SG; Stein R; Garty J; Arieff AI; Coburn JW; Norman AW; Friedler RM Kidney Int; 1976 Jun; 9(6):467-74. PubMed ID: 940279 [TBL] [Abstract][Full Text] [Related]
3. Calcemic response to parathyroid hormone in renal failure: role of calcitriol and the effect of parathyroidectomy. Rodriguez M; Felsenfeld AJ; Llach F Kidney Int; 1991 Dec; 40(6):1063-8. PubMed ID: 1762307 [TBL] [Abstract][Full Text] [Related]
4. Calcemic response to parathyroid hormone in renal failure: role of phosphorus and its effect on calcitriol. Rodriguez M; Martin-Malo A; Martinez ME; Torres A; Felsenfeld AJ; Llach F Kidney Int; 1991 Dec; 40(6):1055-62. PubMed ID: 1762306 [TBL] [Abstract][Full Text] [Related]
5. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis. Brandi L Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159 [TBL] [Abstract][Full Text] [Related]
7. A new analog of 1,25-(OH)2D3, 19-NOR-1,25-(OH)2D2, suppresses serum PTH and parathyroid gland growth in uremic rats without elevation of intestinal vitamin D receptor content. Takahashi F; Finch JL; Denda M; Dusso AS; Brown AJ; Slatopolsky E Am J Kidney Dis; 1997 Jul; 30(1):105-12. PubMed ID: 9214408 [TBL] [Abstract][Full Text] [Related]
8. The influence of 24,25(OH)2D3 on the calcemic effect of 1,25(OH)2D in rats with chronic renal failure is parathyroid hormone dependent. Rubinger D; Krause Y; Krause I; Popovtzer MM Proc Soc Exp Biol Med; 1990 Oct; 195(1):13-7. PubMed ID: 2399255 [TBL] [Abstract][Full Text] [Related]
9. Regulation of 1,25-dihydroxyvitamin D3 by calcium in the parathyroidectomized, parathyroid hormone-replete rat. Weisinger JR; Favus MJ; Langman CB; Bushinsky DA J Bone Miner Res; 1989 Dec; 4(6):929-35. PubMed ID: 2610024 [TBL] [Abstract][Full Text] [Related]
10. Suppression of PTH and decreased action on bone are partially responsible for the low calcemic activity of 22-oxacalcitriol relative to 1,25-(OH)2D3. Finch JL; Brown AJ; Mori T; Nishii Y; Slatopolsky E J Bone Miner Res; 1992 Jul; 7(7):835-9. PubMed ID: 1642151 [TBL] [Abstract][Full Text] [Related]
11. Reversal of skeletal resistance to parathyroid hormone in uremia by vitamin D metabolites: evidence for the requirement of 1,25(OH)2D3 and 24,25(OH)2D3. Massry SG; Tuma S; Dua S; Goldstein DA J Lab Clin Med; 1979 Jul; 94(1):152-7. PubMed ID: 469372 [TBL] [Abstract][Full Text] [Related]
12. Is skeletal response to parathyroid hormone abnormal in experimental renal failure? Patel S; Hsu CH J Lab Clin Med; 1988 Sep; 112(3):387-93. PubMed ID: 3411200 [TBL] [Abstract][Full Text] [Related]
13. The actions of parathyroid hormone on bone: relation to bone remodeling and turnover, calcium homeostasis, and metabolic bone disease. Part IV of IV parts: The state of the bones in uremic hyperaparathyroidism--the mechanisms of skeletal resistance to PTH in renal failure and pseudohypoparathyroidism and the role of PTH in osteoporosis, osteopetrosis, and osteofluorosis. Parfitt AM Metabolism; 1976 Oct; 25(10):1157-88. PubMed ID: 787723 [TBL] [Abstract][Full Text] [Related]
14. Role of parathyroid hormone in the glucose intolerance of chronic renal failure. Akmal M; Massry SG; Goldstein DA; Fanti P; Weisz A; DeFronzo RA J Clin Invest; 1985 Mar; 75(3):1037-44. PubMed ID: 3884663 [TBL] [Abstract][Full Text] [Related]
15. The role of phosphorus in the genesis of azotemic osteodystrophy. Somerville PJ; Kaye M Prog Biochem Pharmacol; 1980; 17():228-35. PubMed ID: 6894195 [TBL] [Abstract][Full Text] [Related]
16. Calcemic and phosphaturic response to parathyroid hormone in normal and chronically uremic dogs. Jacob AI; Gavellas G; Canterbury J; Bourgoignie JJ Kidney Int; 1982 Jul; 22(1):21-6. PubMed ID: 6896896 [TBL] [Abstract][Full Text] [Related]
17. Abnormal skeletal response to parathyroid hormone in dogs with chronic uremia. Olgaard K; Arbelaez M; Schwartz J; Klahr S; Slatopolsky E Calcif Tissue Int; 1982 Jul; 34(4):403-7. PubMed ID: 6291732 [TBL] [Abstract][Full Text] [Related]
18. A new analog of calcitriol, 19-nor-1,25-(OH)2D2, suppresses parathyroid hormone secretion in uremic rats in the absence of hypercalcemia. Slatopolsky E; Finch J; Ritter C; Denda M; Morrissey J; Brown A; DeLuca H Am J Kidney Dis; 1995 Nov; 26(5):852-60. PubMed ID: 7485144 [TBL] [Abstract][Full Text] [Related]
19. In vivo regulation of chromogranin A messenger ribonucleic acid in the parathyroid by 1,25-dihydroxyvitamin D: studies in normal rats and in chronic renal insufficiency. Soliman E; Canaff L; Fox J; Hendy GN Endocrinology; 1997 Jun; 138(6):2596-600. PubMed ID: 9165053 [TBL] [Abstract][Full Text] [Related]
20. Differential regulation of PHEX expression in bone and parathyroid gland by chronic renal insufficiency and 1,25-dihydroxyvitamin D3. Brewer AJ; Canaff L; Hendy GN; Tenenhouse HS Am J Physiol Renal Physiol; 2004 Apr; 286(4):F739-48. PubMed ID: 14693675 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]